229 related articles for article (PubMed ID: 37378812)
1. The advance of CCN3 in fibrosis.
Yin H; Liu N; Zhou X; Chen J; Duan L
J Cell Commun Signal; 2023 Dec; 17(4):1219-1227. PubMed ID: 37378812
[TBL] [Abstract][Full Text] [Related]
2. CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.
Riser BL; Najmabadi F; Perbal B; Peterson DR; Rambow JA; Riser ML; Sukowski E; Yeger H; Riser SC
Am J Pathol; 2009 May; 174(5):1725-34. PubMed ID: 19359517
[TBL] [Abstract][Full Text] [Related]
3. CCN3/CCN2 regulation and the fibrosis of diabetic renal disease.
Riser BL; Najmabadi F; Perbal B; Rambow JA; Riser ML; Sukowski E; Yeger H; Riser SC; Peterson DR
J Cell Commun Signal; 2010 Mar; 4(1):39-50. PubMed ID: 20195391
[TBL] [Abstract][Full Text] [Related]
4. Effects of CCN3 on fibroblast proliferation, apoptosis and extracellular matrix production.
Ren Z; Hou Y; Ma S; Tao Y; Li J; Cao H; Ji L
Int J Mol Med; 2014 Jun; 33(6):1607-12. PubMed ID: 24715059
[TBL] [Abstract][Full Text] [Related]
5. Yin/Yang expression of CCN family members: Transforming growth factor beta 1, via ALK5/FAK/MEK, induces CCN1 and CCN2, yet suppresses CCN3, expression in human dermal fibroblasts.
Peidl A; Perbal B; Leask A
PLoS One; 2019; 14(6):e0218178. PubMed ID: 31170244
[TBL] [Abstract][Full Text] [Related]
6. Anti-fibrotic effect of CCN3 accompanied by altered gene expression profile of the CCN family.
Abd El Kader T; Kubota S; Janune D; Nishida T; Hattori T; Aoyama E; Perbal B; Kuboki T; Takigawa M
J Cell Commun Signal; 2013 Mar; 7(1):11-8. PubMed ID: 23065484
[TBL] [Abstract][Full Text] [Related]
7. CCN3 suppresses TGF-β1-induced extracellular matrix accumulation in human mesangial cells in vitro.
Liu HF; Liu H; Lv LL; Ma KL; Wen Y; Chen L; Liu BC
Acta Pharmacol Sin; 2018 Feb; 39(2):222-229. PubMed ID: 28858296
[TBL] [Abstract][Full Text] [Related]
8. Molecular and Genetic Interactions between CCN2 and CCN3 behind Their Yin-Yang Collaboration.
Kubota S; Kawata K; Hattori T; Nishida T
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682564
[TBL] [Abstract][Full Text] [Related]
9. CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC.
Borkham-Kamphorst E; van Roeyen CR; Van de Leur E; Floege J; Weiskirchen R
J Cell Commun Signal; 2012 Mar; 6(1):11-25. PubMed ID: 21748432
[TBL] [Abstract][Full Text] [Related]
10. Cooperative regulation of chondrocyte differentiation by CCN2 and CCN3 shown by a comprehensive analysis of the CCN family proteins in cartilage.
Kawaki H; Kubota S; Suzuki A; Lazar N; Yamada T; Matsumura T; Ohgawara T; Maeda T; Perbal B; Lyons KM; Takigawa M
J Bone Miner Res; 2008 Nov; 23(11):1751-64. PubMed ID: 18597638
[TBL] [Abstract][Full Text] [Related]
11. Decreased CCN3 in Systemic Sclerosis Endothelial Cells Contributes to Impaired Angiogenesis.
Henrot P; Moisan F; Laurent P; Manicki P; Kaulanjan-Checkmodine P; Jolivel V; Rezvani HR; Leroy V; Picard F; Boulon C; Schaeverbeke T; Seneschal J; Lazaro E; Taïeb A; Truchetet ME; Cario M
J Invest Dermatol; 2020 Jul; 140(7):1427-1434.e5. PubMed ID: 31954725
[TBL] [Abstract][Full Text] [Related]
12. Adenoviral CCN3/NOV gene transfer fails to mitigate liver fibrosis in an experimental bile duct ligation model because of hepatocyte apoptosis.
Borkham-Kamphorst E; Huss S; Van de Leur E; Haas U; Weiskirchen R
Liver Int; 2012 Oct; 32(9):1342-53. PubMed ID: 22698069
[TBL] [Abstract][Full Text] [Related]
13. Metabolic regulation of the CCN family genes by glycolysis in chondrocytes.
Akashi S; Nishida T; El-Seoudi A; Takigawa M; Iida S; Kubota S
J Cell Commun Signal; 2018 Mar; 12(1):245-252. PubMed ID: 29129024
[TBL] [Abstract][Full Text] [Related]
14. Degradomic and yeast 2-hybrid inactive catalytic domain substrate trapping identifies new membrane-type 1 matrix metalloproteinase (MMP14) substrates: CCN3 (Nov) and CCN5 (WISP2).
Butler GS; Connor AR; Sounni NE; Eckhard U; Morrison CJ; Noël A; Overall CM
Matrix Biol; 2017 May; 59():23-38. PubMed ID: 27471094
[TBL] [Abstract][Full Text] [Related]
15. ALK1 heterozygosity increases extracellular matrix protein expression, proliferation and migration in fibroblasts.
Muñoz-Félix JM; Perretta-Tejedor N; Eleno N; López-Novoa JM; Martínez-Salgado C
Biochim Biophys Acta; 2014 Jun; 1843(6):1111-22. PubMed ID: 24594380
[TBL] [Abstract][Full Text] [Related]
16. Recent progress on the role of cellular communication network factors (CCN) 3, 4 and 6 in regulating adiposity, liver fibrosis and pancreatic islets.
Xega V; Alami T; Liu JL
J Cell Commun Signal; 2023 Jun; 17(2):297-306. PubMed ID: 37245185
[TBL] [Abstract][Full Text] [Related]
17. The Emerging Roles of CCN3 Protein in Immune-Related Diseases.
Peng L; Wei Y; Shao Y; Li Y; Liu N; Duan L
Mediators Inflamm; 2021; 2021():5576059. PubMed ID: 34393649
[TBL] [Abstract][Full Text] [Related]
18. CCN3, a key matricellular protein, distinctly inhibits TGFβ1-mediated Smad1/5/8 signalling in human podocyte culture.
Madne TH; Dockrell MEC
Cell Mol Biol (Noisy-le-grand); 2018 Feb; 64(3):5-10. PubMed ID: 29506624
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the CCN genes by vitamin D: A possible adjuvant therapy in the treatment of cancer and fibrosis.
Piszczatowski RT; Lents NH
Cell Signal; 2016 Oct; 28(10):1604-13. PubMed ID: 27460560
[TBL] [Abstract][Full Text] [Related]
20. Reduced NOV/CCN3 Expression Limits Inflammation and Interstitial Renal Fibrosis after Obstructive Nephropathy in Mice.
Marchal PO; Kavvadas P; Abed A; Kazazian C; Authier F; Koseki H; Hiraoka S; Boffa JJ; Martinerie C; Chadjichristos CE
PLoS One; 2015; 10(9):e0137876. PubMed ID: 26367310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
